TSP predicts chemotherapy resistance and survival outcomes in ovarian cancer
Tumor-stromal proportion (TSP) was found to be a consistent and reproducible marker of survival outcome and resistance to standard platinum-based chemotherapy in patients with high-grade serous ovarian cancer, supporting its …
